|
|
Volumn 5, Issue 4, 2005, Pages 261-262
|
|
Levodopa and the progression of Parkinson's disease.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER;
CARRIER PROTEIN;
COCAINE;
DOPAMINE;
DOPAMINE TRANSPORTER;
DRUG DERIVATIVE;
LEVODOPA;
MEMBRANE PROTEIN;
NERVE PROTEIN;
AGED;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORPUS STRIATUM;
DISEASE COURSE;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FEMALE;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
MULTICENTER STUDY;
NERVE DEGENERATION;
OXIDATIVE STRESS;
PARKINSON DISEASE;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
SCINTISCANNING;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
SUBSTANTIA NIGRA;
SYNAPTOSOME;
TREATMENT OUTCOME;
AGED;
COCAINE;
CORPUS STRIATUM;
DISEASE PROGRESSION;
DOPAMINE;
DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
LEVODOPA;
MALE;
MEMBRANE GLYCOPROTEINS;
MEMBRANE TRANSPORT PROTEINS;
MIDDLE AGED;
NERVE DEGENERATION;
NERVE TISSUE PROTEINS;
OXIDATIVE STRESS;
PARKINSON DISEASE;
PRESYNAPTIC TERMINALS;
SUBSTANTIA NIGRA;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
TREATMENT OUTCOME;
|
|
EID: 27244458503
PISSN: 15284042
EISSN: None
Source Type: Journal
DOI: 10.1007/s11910-005-0069-1 Document Type: Article |
|
Times cited : (12)
|
|
References (0)
|
